Form 4: Director Ramona Sequeira Receives Edwards Lifesciences RSU

Sentiment:

Statement of Changes in Beneficial Ownership


Director Ramona Sequeira was granted 3,251 restricted stock units as part of the Edwards Lifesciences 2020 Nonemployee Directors Stock Incentive Program.

Summary

  • Director Ramona Sequeira acquired 3,251 restricted stock units (RSUs) on May 8, 2026.
  • The grant was issued under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
  • The units are scheduled to vest fully after one year or at the next annual meeting of stockholders, whichever occurs first.
  • Following this transaction, the director's direct beneficial ownership increased to 6,779 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • None identified.

Risks

  • Standard market risks associated with equity ownership and potential fluctuations in the company's share price.

Future Outlook

The RSUs are set to vest in one year or upon the next annual meeting of stockholders, indicating a standard retention and incentive structure for board members.

Industry Context

StockSavvy.ai notes that this is a routine equity grant for a board member, consistent with standard corporate governance practices in the medical device industry to ensure director alignment with company performance.

Comparison to Industry Standards

  • The grant follows standard industry practices for non-employee director compensation packages.
  • The vesting schedule is consistent with typical annual equity refresh cycles for S&P 500 companies.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

  • Vesting of the 3,251 restricted stock units in May 2027 or at the next annual meeting.

Key Dates

DateDescription
05/08/2026Grant date of restricted stock units and date of transaction.

Keywords

Edwards Lifesciences, EW, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.